Department of Pediatric and Preventive Dentistry, Karnavati School of Dentistry, Karnavati University, Gandhinagar, Gujarat, India.
J Indian Soc Pedod Prev Dent. 2023 Apr-Jun;41(2):149-155. doi: 10.4103/jisppd.jisppd_199_23.
insulin syringe for anesthetizing primary maxillary teeth in children aged 4-9 years.
This randomized clinical study included 46 children aged 4-9 years. The patients were digitally allotted to receive 4% articaine for extractions of primary maxillary teeth, either using needleless device INJEX or insulin syringe on each side of the maxillary arch, in two different appointments after a 1-week washout period. Pain perception was measured by the subjective (Faces Pain Scale-Revised [FPS-R]) and objective pain scores (Face, Legs, Activity, Cry, and Consolability [FLACC]) and hemodynamic parameters (heart rate and oxygen saturation) during LA administration and during extractions. After the second appointment, children were asked about their preference between needleless device INJEX and insulin syringe.
On evaluating subjective pain scores with FPS-R, intergroup differences between the INJEX and insulin syringe groups were found statistically insignificant, both during LA administration (P = 0.101) and extraction (P = 0.080). However, on assessing pain objectively during extraction using FLACC, the mean pain score was less with insulin syringe (2.78) as compared to INJEX (4.72) and the difference was statistically significant (P = 0.000). There was no significant difference in patient preference between the two methods.
Pain perception was minimal during local anesthesia administration using needleless device INJEX; however, its clinical efficacy during extractions was reported to be lower than insulin syringe.
Managing pain in children is the most challenging task as it forms the foundation for instilling positive behavior toward dental treatment. Adequate local anesthesia (LA) is the cornerstone of pain management. However, the fear of needles, particularly in young children, can result in complete avoidance and refusal of treatment.
This study aimed to evaluate and compare the efficacy and preference between needleless device INJEX and.
用于麻醉 4-9 岁儿童上颌第一磨牙的胰岛素注射器。
这是一项随机临床研究，纳入了 46 名 4-9 岁的儿童。患者按数字随机分配，在每侧上颌弓的颊侧接受 4%阿替卡因用于上颌第一磨牙的拔除，使用无针装置 INJEX 或胰岛素注射器，两次就诊之间间隔 1 周洗脱期。疼痛感知通过主观（修订面部疼痛量表[FPS-R]）和客观疼痛评分（面部、腿部、活动、哭泣和安慰性[FLACC]）以及局部麻醉给药期间和拔牙期间的血流动力学参数（心率和血氧饱和度）进行测量。在第二次就诊后，询问儿童对无针装置 INJEX 和胰岛素注射器的偏好。
用 FPS-R 评估主观疼痛评分时，INJEX 组和胰岛素注射器组之间的组间差异无统计学意义，无论是在局部麻醉给药期间（P=0.101）还是在拔牙期间（P=0.080）。然而，在使用 FLACC 评估拔牙过程中的客观疼痛时，胰岛素注射器的平均疼痛评分（2.78）低于 INJEX（4.72），差异有统计学意义（P=0.000）。两种方法之间的患者偏好无显著差异。
使用无针装置 INJEX 进行局部麻醉给药时疼痛感知最小；然而，其在拔牙过程中的临床效果报告低于胰岛素注射器。
管理儿童疼痛是最具挑战性的任务，因为它是树立对牙科治疗积极行为的基础。足够的局部麻醉（LA）是疼痛管理的基石。然而，特别是在年幼的儿童中，对针头的恐惧可能导致完全避免和拒绝治疗。
本研究旨在评估和比较无针装置 INJEX 和胰岛素注射器的疗效和偏好。
